United Kingdom (UK) Non-Oncology Precision Medicine Market (2025-2031) Outlook | Size, Forecast, Share, Trends, Companies, Growth, Industry, Analysis, Value & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Non-Oncology Precision Medicine Market - Industry Life Cycle

3.4 United Kingdom (UK) Non-Oncology Precision Medicine Market - Porter's Five Forces

3.5 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume Share, By Form, 2021 & 2031F

3.6 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of non-oncology diseases in the UK

4.2.2 Growing adoption of precision medicine technologies and personalized treatment approaches

4.2.3 Government initiatives and funding to promote precision medicine research and development

4.3 Market Restraints

4.3.1 High costs associated with precision medicine testing and treatments

4.3.2 Limited availability and accessibility of precision medicine services in certain regions of the UK

4.3.3 Regulatory challenges and uncertainties related to the approval and reimbursement of precision medicine therapies

6.1 United Kingdom (UK) Non-Oncology Precision Medicine Market, By Application

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2018 - 2027F

6.1.3 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2018 - 2027F

6.1.4 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2018 - 2027F

6.1.5 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2018 - 2027F

6.1.6 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2018 - 2027F

6.1.7 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2018 - 2027F

6.2 United Kingdom (UK) Non-Oncology Precision Medicine Market, By Ecosystem

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2018 - 2027F

6.2.3 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2018 - 2027F

6.2.4 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2018 - 2027F

7.1 United Kingdom (UK) Non-Oncology Precision Medicine Market Export to Major Countries

7.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Imports from Major Countries

8.1 Average time for diagnosis and treatment initiation in non-oncology precision medicine

8.2 Number of clinical trials and research studies focused on non-oncology precision medicine in the UK

8.3 Patient satisfaction scores with personalized treatment plans and outcomes achieved through precision medicine applications.

9.1 United Kingdom (UK) Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F

10.1 United Kingdom (UK) Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2021

10.2 United Kingdom (UK) Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters